Related by context. Frequent words. (Click for all words.) 69 Amrubicin 68 Azedra 68 leukaemias 68 gastrointestinal stromal tumors GIST 68 multiple myeloma MM 67 myeloproliferative disorders 67 TREANDA 67 elotuzumab 67 Epratuzumab 67 proteasome inhibitor 67 forodesine 66 pertuzumab 66 INCB# [001] 66 ixabepilone 66 Jevtana 66 Irinotecan 66 ovarian breast 66 bendamustine 66 leukemia CLL 66 ATL# [001] 66 EGFR inhibitors 65 metastatic hormone refractory 65 hematological cancers 65 registrational trial 65 liposomal formulation 65 Panzem R 65 Vandetanib 65 HER2 positive metastatic breast 65 Acute Myeloid Leukemia AML 65 Alemtuzumab 65 gastrointestinal stromal tumors 65 EndoTAG TM -1 65 heavily pretreated 65 Fludara 65 colorectal carcinoma 65 Zolinza 65 androgen independent 65 ACZ# 64 SERMs 64 FLT3 64 humanized antibody 64 Nexavar ® 64 PEG SN# 64 mRCC 64 carcinoid 64 deforolimus 64 relapsed multiple myeloma 64 EOquin 64 Virulizin R 64 chronic lymphocytic leukemia CLL 64 relapsed refractory multiple myeloma 64 R sorafenib tablets 64 metastatic castration resistant 64 thymalfasin 64 luteinizing hormone releasing 64 OXi# 64 Clevudine 64 acute promyelocytic leukemia APL 63 Everolimus 63 ocrelizumab 63 Dasatinib 63 atacicept 63 decitabine 63 romidepsin 63 hepatitis C HCV 63 anticancer compound 63 Trastuzumab 63 biologic therapy 63 cell chronic lymphocytic 63 EFAPROXYN 63 metastatic renal cell carcinoma 63 cutaneous T cell 63 IMC #B 63 Fibrillex TM 63 Lenalidomide 63 axitinib 63 calcineurin inhibitors 63 Doxil 63 medullary thyroid cancer 63 HCV infections 63 Pirfenidone 63 Advexin 63 enzastaurin 63 Ixempra 63 chronic HCV 63 tanespimycin 63 investigational compounds 63 carcinoid tumors 62 talactoferrin 62 ADVEXIN 62 non Hodgkin lymphomas 62 MEK inhibitor 62 Mipomersen 62 ponatinib 62 HGS ETR1 62 pancreatic neuroendocrine tumors 62 RITUXAN 62 daclizumab 62 LymphoStat B 62 KNS # 62 phase IIb clinical